US Stock MarketDetailed Quotes

Xilio Therapeutics (XLO)

Watchlist
  • 7.760
  • +0.030+0.39%
Close May 13 16:00 ET
  • 7.760
  • 0.0000.00%
Post 16:04 ET
46.43MMarket Cap-3.40P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Xilio Therapeutics (XLO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-177.10%-22.34M
72.84%-4.99M
85.89%-2M
-27.96%-17.5M
-172.56%-14.48M
375.93%28.98M
73.22%-18.38M
-5.44%-14.16M
-2.27%-13.67M
220.39%19.95M
Net income from continuing operations
28.16%-9.53M
39.84%-35.04M
179.13%10.36M
-16.17%-16.29M
-13.78%-15.84M
22.89%-13.27M
23.77%-58.24M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
Operating gains losses
---3.3M
-118,800.00%-3.56M
-2,127,600.00%-21.28M
--15.38M
----
----
0.00%3K
--1K
----
----
Depreciation and amortization
-30.78%344K
-6.27%1.54M
-14.10%323K
-10.53%340K
-14.38%381K
12.19%497K
-13.47%1.64M
-16.26%376K
-17.39%380K
-9.55%445K
Other non cash items
----
----
----
----
----
----
----
----
--0
--0
Change In working capital
-130.01%-12.07M
-20.95%25.13M
291.55%5.66M
-1,022.57%-18.05M
-108.45%-2.7M
808.72%40.21M
2,016.89%31.78M
-261.32%-2.96M
-255.51%-1.61M
7,880.50%31.92M
-Change in receivables
--5M
---5M
--12.5M
----
----
--0
--0
--0
----
----
-Change in prepaid assets
-225.00%-1.21M
413.46%3.08M
118.00%495K
-143.63%-500K
-12.02%2.12M
154.10%964K
-242.59%-981K
-314.01%-2.75M
168.79%1.15M
262.75%2.41M
-Change in payables and accrued expense
53.83%-3.22M
-4,764.71%-827K
-10.61%1.36M
408.35%1.51M
86.06%3.27M
-148.79%-6.97M
99.10%-17K
128.12%1.52M
-117.42%-491K
1,311.72%1.76M
-Change in other current assets
----
----
----
----
----
16.54%148K
17.17%539K
17.21%143K
17.09%137K
16.81%132K
-Change in other current liabilities
----
----
----
----
----
-13.93%-278K
-14.05%-1.05M
-14.23%-273K
-13.62%-267K
-13.85%-263K
-Change in other working capital
-127.37%-12.65M
-14.96%27.88M
-403.89%-8.69M
30.84%-1.57M
-242.98%-8.08M
18.12%46.21M
--32.78M
---1.72M
---2.26M
---2.36M
Cash from discontinued investing activities
Operating cash flow
-177.10%-22.34M
72.84%-4.99M
85.89%-2M
-27.96%-17.5M
-172.56%-14.48M
375.93%28.98M
73.22%-18.38M
-5.44%-14.16M
-2.27%-13.67M
220.39%19.95M
Investing cash flow
Cash flow from continuing investing activities
-2,427.27%-556K
-1,338.89%-518K
-1,483.33%-95K
0
-1,809.52%-401K
-22K
92.59%-36K
-6K
-9K
93.35%-21K
Net PPE purchase and sale
-2,427.27%-556K
-1,338.89%-518K
-1,483.33%-95K
--0
-1,809.52%-401K
---22K
92.59%-36K
---6K
---9K
93.35%-21K
Cash from discontinued investing activities
Investing cash flow
-2,427.27%-556K
-1,338.89%-518K
-1,483.33%-95K
--0
-1,809.52%-401K
---22K
92.59%-36K
---6K
---9K
93.35%-21K
Financing cash flow
Cash flow from continuing financing activities
638.97%35.71M
200.64%87.78M
337.28%35.87M
-9,400.00%-285K
136.30%47.36M
406.50%4.83M
545.74%29.2M
601.96%8.2M
99.87%-3K
2,120.46%20.04M
Net issuance payments of debt
----
--0
--0
--0
--0
--0
49.91%-3.38M
--0
99.69%-7K
98.14%-21K
Net common stock issuance
--0
495.68%40.66M
304.59%35.83M
-370.19%-47.32M
1,780.68%47.32M
12.05%4.83M
--6.83M
---17.51M
--17.51M
--2.52M
Proceeds from stock option exercised by employees
745,040.00%37.26M
82.97%47.12M
-99.85%38K
368.62%47.03M
-99.75%44K
--5K
12,649.01%25.75M
47,518.52%25.71M
-218,962.50%-17.51M
--17.55M
Net other financing activities
---1.55M
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
638.97%35.71M
200.64%87.78M
337.28%35.87M
-9,400.00%-285K
136.30%47.36M
406.50%4.83M
545.74%29.2M
601.96%8.2M
99.87%-3K
2,120.46%20.04M
Net cash flow
Beginning cash position
144.14%139.34M
23.29%57.07M
67.47%105.57M
60.78%123.35M
147.29%90.86M
23.29%57.07M
-62.04%46.29M
2.74%63.03M
-0.31%76.72M
-61.26%36.74M
Current changes in cash
-62.09%12.81M
662.98%82.27M
666.57%33.77M
-29.93%-17.78M
-18.74%32.48M
453.88%33.79M
114.25%10.78M
60.42%-5.96M
12.31%-13.68M
323.55%39.98M
End cash Position
67.45%152.15M
144.14%139.34M
144.14%139.34M
67.47%105.57M
60.78%123.35M
147.29%90.86M
23.29%57.07M
23.29%57.07M
2.74%63.03M
-0.31%76.72M
Free cash flow
-179.08%-22.9M
70.08%-5.51M
85.22%-2.09M
-27.88%-17.5M
-174.64%-14.88M
375.72%28.96M
73.35%-18.41M
-5.48%-14.16M
-2.33%-13.68M
218.01%19.93M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -177.10%-22.34M72.84%-4.99M85.89%-2M-27.96%-17.5M-172.56%-14.48M375.93%28.98M73.22%-18.38M-5.44%-14.16M-2.27%-13.67M220.39%19.95M
Net income from continuing operations 28.16%-9.53M39.84%-35.04M179.13%10.36M-16.17%-16.29M-13.78%-15.84M22.89%-13.27M23.77%-58.24M25.84%-13.09M16.29%-14.02M28.05%-13.93M
Operating gains losses ---3.3M-118,800.00%-3.56M-2,127,600.00%-21.28M--15.38M--------0.00%3K--1K--------
Depreciation and amortization -30.78%344K-6.27%1.54M-14.10%323K-10.53%340K-14.38%381K12.19%497K-13.47%1.64M-16.26%376K-17.39%380K-9.55%445K
Other non cash items ----------------------------------0--0
Change In working capital -130.01%-12.07M-20.95%25.13M291.55%5.66M-1,022.57%-18.05M-108.45%-2.7M808.72%40.21M2,016.89%31.78M-261.32%-2.96M-255.51%-1.61M7,880.50%31.92M
-Change in receivables --5M---5M--12.5M----------0--0--0--------
-Change in prepaid assets -225.00%-1.21M413.46%3.08M118.00%495K-143.63%-500K-12.02%2.12M154.10%964K-242.59%-981K-314.01%-2.75M168.79%1.15M262.75%2.41M
-Change in payables and accrued expense 53.83%-3.22M-4,764.71%-827K-10.61%1.36M408.35%1.51M86.06%3.27M-148.79%-6.97M99.10%-17K128.12%1.52M-117.42%-491K1,311.72%1.76M
-Change in other current assets --------------------16.54%148K17.17%539K17.21%143K17.09%137K16.81%132K
-Change in other current liabilities ---------------------13.93%-278K-14.05%-1.05M-14.23%-273K-13.62%-267K-13.85%-263K
-Change in other working capital -127.37%-12.65M-14.96%27.88M-403.89%-8.69M30.84%-1.57M-242.98%-8.08M18.12%46.21M--32.78M---1.72M---2.26M---2.36M
Cash from discontinued investing activities
Operating cash flow -177.10%-22.34M72.84%-4.99M85.89%-2M-27.96%-17.5M-172.56%-14.48M375.93%28.98M73.22%-18.38M-5.44%-14.16M-2.27%-13.67M220.39%19.95M
Investing cash flow
Cash flow from continuing investing activities -2,427.27%-556K-1,338.89%-518K-1,483.33%-95K0-1,809.52%-401K-22K92.59%-36K-6K-9K93.35%-21K
Net PPE purchase and sale -2,427.27%-556K-1,338.89%-518K-1,483.33%-95K--0-1,809.52%-401K---22K92.59%-36K---6K---9K93.35%-21K
Cash from discontinued investing activities
Investing cash flow -2,427.27%-556K-1,338.89%-518K-1,483.33%-95K--0-1,809.52%-401K---22K92.59%-36K---6K---9K93.35%-21K
Financing cash flow
Cash flow from continuing financing activities 638.97%35.71M200.64%87.78M337.28%35.87M-9,400.00%-285K136.30%47.36M406.50%4.83M545.74%29.2M601.96%8.2M99.87%-3K2,120.46%20.04M
Net issuance payments of debt ------0--0--0--0--049.91%-3.38M--099.69%-7K98.14%-21K
Net common stock issuance --0495.68%40.66M304.59%35.83M-370.19%-47.32M1,780.68%47.32M12.05%4.83M--6.83M---17.51M--17.51M--2.52M
Proceeds from stock option exercised by employees 745,040.00%37.26M82.97%47.12M-99.85%38K368.62%47.03M-99.75%44K--5K12,649.01%25.75M47,518.52%25.71M-218,962.50%-17.51M--17.55M
Net other financing activities ---1.55M------------------------------------
Cash from discontinued financing activities
Financing cash flow 638.97%35.71M200.64%87.78M337.28%35.87M-9,400.00%-285K136.30%47.36M406.50%4.83M545.74%29.2M601.96%8.2M99.87%-3K2,120.46%20.04M
Net cash flow
Beginning cash position 144.14%139.34M23.29%57.07M67.47%105.57M60.78%123.35M147.29%90.86M23.29%57.07M-62.04%46.29M2.74%63.03M-0.31%76.72M-61.26%36.74M
Current changes in cash -62.09%12.81M662.98%82.27M666.57%33.77M-29.93%-17.78M-18.74%32.48M453.88%33.79M114.25%10.78M60.42%-5.96M12.31%-13.68M323.55%39.98M
End cash Position 67.45%152.15M144.14%139.34M144.14%139.34M67.47%105.57M60.78%123.35M147.29%90.86M23.29%57.07M23.29%57.07M2.74%63.03M-0.31%76.72M
Free cash flow -179.08%-22.9M70.08%-5.51M85.22%-2.09M-27.88%-17.5M-174.64%-14.88M375.72%28.96M73.35%-18.41M-5.48%-14.16M-2.33%-13.68M218.01%19.93M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -